| Original language | English |
|---|---|
| Pages (from-to) | 263-265 |
| Number of pages | 3 |
| Journal | Blood |
| Volume | 131 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Jan 11 2018 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology
Cite this
Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia : Results from a phase 2a study. / Taher, Ali T.; Karakas, Zeynep; Cassinerio, Elena; Siritanaratkul, Noppadol; Kattamis, Antonis; Maggio, Aurelio; Rivella, Stefano; Hollaender, Norbert; Mahuzier, Bruyere; Gadbaw, Brian; Aydinok, Yesim.
In: Blood, Vol. 131, No. 2, 11.01.2018, p. 263-265.Research output: Contribution to journal › Letter
}
TY - JOUR
T1 - Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia
T2 - Results from a phase 2a study
AU - Taher, Ali T.
AU - Karakas, Zeynep
AU - Cassinerio, Elena
AU - Siritanaratkul, Noppadol
AU - Kattamis, Antonis
AU - Maggio, Aurelio
AU - Rivella, Stefano
AU - Hollaender, Norbert
AU - Mahuzier, Bruyere
AU - Gadbaw, Brian
AU - Aydinok, Yesim
PY - 2018/1/11
Y1 - 2018/1/11
UR - http://www.scopus.com/inward/record.url?scp=85040441699&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85040441699&partnerID=8YFLogxK
U2 - 10.1182/blood-2017-06-790121
DO - 10.1182/blood-2017-06-790121
M3 - Letter
VL - 131
SP - 263
EP - 265
JO - Blood
JF - Blood
SN - 0006-4971
IS - 2
ER -